0
Other Articles |

THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH CONCENTRATED RABBIT SERUM

ITALO F. VOLINI, M.D.; ROBERT O. LEVITT, M.D.
JAMA. 1939;113(14):1314-1316. doi:10.1001/jama.1939.02800390036010.
Text Size: A A A
Published online

There have been few reports submitted concerning the use of rabbit serum in the type specific therapy of pneumonia. This is particularly true of the concentrated and refined serum. The steadily increasing improvements in the character of the serum have indicated the fulfilment of the factors defining a good serum for therapy; namely, first that the intravenous administration be without undue reaction and second that the adequate dose be contained in a small volume. The theoretical and practical advantages that antipneumococcus rabbit serum possesses over horse serum have been pointed out by several observers.1 These observations, however, have been made with the unconcentrated rabbit serum. Finland and Brown2 describe the use of the concentrated serum in sixteen cases with two deaths in type I pneumonia. The present report deals with the administration of concentrated and refined rabbit serum in 153 patients, comprising twenty-one different types of pneumococcic infection.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs